Home・Elenco Azioni・Certara Inc

Certara Inc

Chiusa

SettoreSettore sanitario

8.07 -1.22

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

7.99

Massimo

8.18

Metriche Chiave
By Trading Economics
Entrata	-2.9M -8.8M
Vendite	3.3M 107M
P/E Media del settore	100.714 68.51
EPS	0.09
Margine di Profitto	-8.196
Dipendenti	1,515
EBITDA	-16M 16M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+1.73% upside

Dividendi
By Acuity
Utili prossimi	5 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	474M 1.3B
Apertura precedente	9.29
Chiusura precedente	8.07

Notizie sul Sentiment di mercato

By Acuity

50%

128 / 340 Classifica in Healthcare

Certara Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 ago 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 ago 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 ago 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4 ago 2026, 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3 ago 2026, 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31 lug 2026, 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30 lug 2026, 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29 lug 2026, 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

28 lug 2026, 18:36 UTC

Certara Inc is higher during Tuesday's session, continuing gains from Monday. The stock remains above its 20-day moving average despite an intraday pullback.

27 lug 2026, 19:07 UTC

Certara Inc shares are trading higher during Monday's session, reflecting positive momentum since Friday's close, despite no specific company news identified.

24 lug 2026, 18:02 UTC

Certara Inc shares are trading higher today, continuing gains since Thursday's close. No specific news was identified to explain the upward movement.

23 lug 2026, 20:06 UTC

Shares of Certara Inc are higher during Thursday's session, continuing a notable increase since Wednesday's close. No specific news was identified for this movement.

22 lug 2026, 20:04 UTC

Certara Inc's shares are higher during Wednesday's session, recovering from an early decline amid broader market uncertainty ahead of the Federal Reserve meeting.

20 lug 2026, 19:31 UTC

News

Certara Inc partners with NVIDIA to enhance its AI biosimulation platform. Shares are higher, reflecting positive market sentiment around the collaboration.

Confronto tra pari

Modifica del prezzo

Certara Inc Previsione

Obiettivo di Prezzo

By TipRanks

1.73% in crescita

Previsioni per 12 mesi

Media 8.21 USD 1.73%

Alto 9 USD

Basso 7 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Certara Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

9 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 9 che hanno fornito valutazioni azionarie a Certara Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

128 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.